Causal effects of gut microbiota on autism spectrum disorder: A two-sample mendelian randomization study
- PMID: 38428908
- PMCID: PMC10906619
- DOI: 10.1097/MD.0000000000037284
Causal effects of gut microbiota on autism spectrum disorder: A two-sample mendelian randomization study
Abstract
There is increasing evidence that alterations in gut microbiota (GM) composition are associated with autism spectrum disorder (ASD), but no reliable causal relationship has been established. Therefore, a 2-sample Mendelian randomization (MR) study was conducted to reveal a potential causal relationship between GM and ASD. Instrumental variables for 211 GM taxa were obtained from genome-wide association studies (GWAS) and Mendelian randomization studies to estimate their impact on ASD risk in the iPSYCH-PGC GWAS dataset (18,382 ASD cases and 27,969 controls). Inverse variance weighted (IVW) is the primary method for causality analysis, and several sensitivity analyses validate MR results. Among 211 GM taxa, IVW results confirmed that Tenericutes (P value = .0369), Mollicutes (P value = .0369), Negativicutes (P value = .0374), Bifidobacteriales (P value = .0389), Selenomonadales (P value = .0374), Bifidobacteriaceae (P value = .0389), Family XIII (P value = .0149), Prevotella7 (P value = .0215), Ruminococcaceae NK4A214 group (P value = .0205) were potential protective factors for ASD. Eisenbergiella (P value = .0159) was a possible risk factor for ASD. No evidence of heterogeneous, pleiotropic, or outlier single-nucleotide polymorphism was detected. Additionally, further sensitivity analysis verified the robustness of the above results. We confirm a potential causal relationship between certain gut microbes and ASD, providing new insights into how gut microbes mediate ASD. The association between them needs to be further explored and will provide new ideas for the prevention and treatment of ASD.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures



Similar articles
-
Genetic evidence supporting the causal role of gut microbiota in chronic kidney disease and chronic systemic inflammation in CKD: a bilateral two-sample Mendelian randomization study.Front Immunol. 2023 Nov 2;14:1287698. doi: 10.3389/fimmu.2023.1287698. eCollection 2023. Front Immunol. 2023. PMID: 38022507 Free PMC article.
-
Gut microbiota and autism spectrum disorders: a bidirectional Mendelian randomization study.Front Cell Infect Microbiol. 2023 Dec 14;13:1267721. doi: 10.3389/fcimb.2023.1267721. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38156319 Free PMC article.
-
Causal associations between human gut microbiota and cholelithiasis: a mendelian randomization study.Front Cell Infect Microbiol. 2023 May 25;13:1169119. doi: 10.3389/fcimb.2023.1169119. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37305422 Free PMC article.
-
Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study.Front Cell Infect Microbiol. 2024 May 22;14:1348685. doi: 10.3389/fcimb.2024.1348685. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38841114 Free PMC article.
-
Exploring the potential causal relationship between gut microbiota and heart failure: A two-sample mendelian randomization study combined with the geo database.Curr Probl Cardiol. 2024 Feb;49(2):102235. doi: 10.1016/j.cpcardiol.2023.102235. Epub 2023 Nov 30. Curr Probl Cardiol. 2024. PMID: 38040216 Review.
Cited by
-
Comprehensive Analysis of Gut Microbiota Composition and Functional Metabolism in Children with Autism Spectrum Disorder and Neurotypical Children: Implications for Sex-Based Differences and Metabolic Dysregulation.Int J Mol Sci. 2024 Jun 18;25(12):6701. doi: 10.3390/ijms25126701. Int J Mol Sci. 2024. PMID: 38928411 Free PMC article.